Annex Advisory Services LLC Has $1.22 Million Stake in Balchem Co. (NASDAQ:BCPC)

Annex Advisory Services LLC lifted its holdings in Balchem Co. (NASDAQ:BCPC) by 35.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,496 shares of the basic materials company’s stock after acquiring an additional 1,959 shares during the quarter. Annex Advisory Services LLC’s holdings in Balchem were worth $1,222,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of BCPC. State Street Corp boosted its stake in Balchem by 1.0% in the third quarter. State Street Corp now owns 1,234,226 shares of the basic materials company’s stock worth $217,224,000 after purchasing an additional 12,006 shares in the last quarter. Conestoga Capital Advisors LLC raised its holdings in shares of Balchem by 1.8% in the third quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company’s stock valued at $206,900,000 after buying an additional 20,360 shares during the last quarter. Geode Capital Management LLC grew its holdings in Balchem by 3.1% during the 3rd quarter. Geode Capital Management LLC now owns 928,904 shares of the basic materials company’s stock worth $163,514,000 after acquiring an additional 27,979 shares during the last quarter. Geneva Capital Management LLC increased its position in Balchem by 1.7% in the 3rd quarter. Geneva Capital Management LLC now owns 779,869 shares of the basic materials company’s stock valued at $137,257,000 after acquiring an additional 12,750 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Balchem by 0.9% in the second quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company’s stock worth $107,372,000 after acquiring an additional 5,977 shares during the last quarter. 87.91% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently commented on BCPC. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright lifted their target price on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research note on Monday, November 4th.

Balchem Stock Down 0.2 %

Shares of NASDAQ BCPC opened at $160.15 on Tuesday. Balchem Co. has a 1 year low of $136.74 and a 1 year high of $186.03. The firm’s 50-day moving average is $170.18 and its 200-day moving average is $170.94. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $5.21 billion, a PE ratio of 43.05, a price-to-earnings-growth ratio of 4.15 and a beta of 0.69.

Balchem Increases Dividend

The firm also recently disclosed an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were paid a $0.87 dividend. The ex-dividend date was Thursday, December 26th. This is a boost from Balchem’s previous annual dividend of $0.79. This represents a yield of 0.4%. Balchem’s dividend payout ratio (DPR) is presently 23.39%.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.